I agree that this site is using cookies. You can find further informations here.
X
Alberati-Giani, Daniela
26  results:
Search for persons X
?
1

Cloning and functional expression of human kynurenine 3‐mon..:

Alberati-Giani, Daniela ; Cesura, Andrea M ; Broger, Clemens...
FEBS Letters.  410 (1997)  2-3 - p. 407-412 , 1997
Link: https://doi.org/10.1016/..
 
?
2

Cloning and Functional Expression of a Soluble Form of Kynu..:

Buchli, Rico ; Alberati-Giani, Daniela ; Malherbe, Pari...
Journal of Biological Chemistry.  270 (1995)  49 - p. 29330-29335 , 1995
Link: https://doi.org/10.1074/..
 
?
3

Expression of the kynurenine enzymes in macrophages and mic..:

Alberati-Giani, D. ; Cesura, A. M.
Amino Acids.  14 (1998)  1-3 - p. 251-255 , 1998
Link: https://doi.org/10.1007/..
 
?
4

OFQ knock-out mice: Behavioral phenotype seems to indicate ..:

Jenck, F. ; Borroni, E. ; Cesura, A.M....
European Neuropsychopharmacology.  8 (1998)  - p. S310 , 1998
Link: https://doi.org/10.1016/..
 
?
5

Regulation of enzymes of the kynurenine pathway by interfer..:

Cesura, A.M. ; Alberati-Giani, D. ; Köhler, C..
Pharmacological Research.  31 (1995)  - p. 125 , 1995
Link: https://doi.org/10.1016/..
 
?
6

Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A..:

Pinard, Emmanuel ; Borroni, Edilio ; Koerner, Annette..
CHIMIA.  72 (2018)  7-8 - p. 477 , 2018
Link: https://doi.org/10.2533/..
 
?
7

Evaluation of the Subjective Similarity of the GlyT1 Inhibi..:

Dinklo, Theo ; Gauvin, David ; Järbe, Torbjörn...
Journal of Pharmacological and Toxicological Methods.  88 (2017)  - p. 191 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Effects of the glycine reuptake inhibitors bitopertin and R..:

Hofmann, Carsten ; Pizzagalli, Flavia ; Boetsch, Christophe...
Psychopharmacology.  233 (2016)  13 - p. 2429-2439 , 2016
Link: https://doi.org/10.1007/..
 
?
9

3-Amido-3-aryl-piperidines: A Novel Class of Potent, Select..:

Pinard, Emmanuel ; Alberati, Daniela ; Alvarez-Sanchez, Ruben...
ACS Medicinal Chemistry Letters.  5 (2014)  4 - p. 428-433 , 2014
Link: https://doi.org/10.1021/..
 
?
10

5:45 PM THE NEUROBIOLOGY OF NEGATIVE SYMPTOMS AND THE EFFEC..:

Alberati, Daniela
Schizophrenia Research.  153 (2014)  - p. S59 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Pre-clinical characterization of [11C]R05013853 as a novel ..:

Borroni, Edilio ; Zhou, Yun ; Ostrowitzki, Susanne...
NeuroImage.  75 (2013)  - p. 291-300 , 2013
Link: https://doi.org/10.1016/..
 
?
12

Physiologically Based Pharmacokinetic Modelling to Predict ..:

Parrott, Neil ; Hainzl, Dominik ; Alberati, Daniela...
Clinical Pharmacokinetics.  52 (2013)  8 - p. 673-683 , 2013
Link: https://doi.org/10.1007/..
 
?
13

Glycine reuptake inhibitor RG1678: A pharmacologic characte..:

Alberati, Daniela ; Moreau, Jean-Luc ; Lengyel, Judith...
Neuropharmacology.  62 (2012)  2 - p. 1152-1161 , 2012
Link: https://doi.org/10.1016/..
 
?
14

A TRANSLATIONAL SUCCESS STORY: FACILITATING NMDA RECEPTOR S..:

Alberati, Daniela
Schizophrenia Research.  136 (2012)  - p. S53 , 2012
Link: https://doi.org/10.1016/..
 
?
15

Inhibiting glycine transporter-1 facilitates cocaine–cue ex..:

Nic Dhonnchadha, Bríd Á. ; Pinard, Emmanuel ; Alberati, Daniela...
Drug and Alcohol Dependence.  122 (2012)  1-2 - p. 119-126 , 2012
Link: https://doi.org/10.1016/..
 
1-15